Categories: Artificial IntelligenceBioTechBuildingDrugLearnPlatform
Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.08.2024 | Series A | $40M | - |
| 07.09.2023 | Seed | $14M | - |
Mentions in press and media 4
| Date | Title | Description |
| 29.08.2024 | Noetik Closes $40M Series A Financing | Noetik, a San Francisco, CA-based AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, closed a $40m Series A financing round.
The round was l... |
| 07.09.2023 | AI-based cancer immunotherapy startup Noetik raises $14M | The company has generated hundreds of terabytes of human data in less than a year
When it comes to developing precision therapeutics in immuno-oncology, the biggest bottleneck is clinical failure, with an ever-growing discovery funnel.
That... |
| 07.09.2023 | Noetik Raises $14M in Seed Financing | Noetik, a San Francisco, CA-based AI drug discovery company, raised $14M in Seed funding.
The round was led by DCVC, with participation from Zetta Venture Partners, 11.2 Capital, Catalio Capital Management, Epic Ventures, Intermountain Vent... |
| - | Noetik | “Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.” |
Reviews 0
